Clinical Trials Logo

Cardiovascular Risk Factors clinical trials

View clinical trials related to Cardiovascular Risk Factors.

Filter by:

NCT ID: NCT02720133 Completed - Fasting Clinical Trials

Ramadan Fasting Effects in Patients With Cardiovascular Risk Factors

Start date: July 2013
Phase: N/A
Study type: Observational [Patient Registry]

Ramadan Fasting has multiple effects on the variation of hematological and biochemical parameters.

NCT ID: NCT02628353 Recruiting - Blood Pressure Clinical Trials

Effect of a Specific Phenolic Compound on Blood Pressure

PHENOLPRESS
Start date: December 2015
Phase: Phase 3
Study type: Interventional

The study's main objective is to investigate the effects of acute consumption of a preparation containing 100 mg of a specific phenolic compound (patent pending, P201531587) on systolic BP after ingestion of a high fat meal.

NCT ID: NCT02626442 Recruiting - Stroke Clinical Trials

Exercise and Brain Health

EBH
Start date: July 2013
Phase: N/A
Study type: Interventional

The risk of stroke and vascular dementia is high in individuals who have had a prior stroke or TIA, and in those who have vascular disease risk factors, such as high blood pressure, abnormal cholesterol, diabetes or pre-diabetes. These vascular risk factors can improve with exercise. This study will examine the impact of a 6 month, low intensity group exercise class on fitness, walking, balance, and brain health. This study will also collect fitness, walking, balance, and brain health outcome measures at baseline and post all other MERCE exercise and robotics interventions.

NCT ID: NCT02589769 Completed - Clinical trials for Cardiovascular Disease

Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons

Start date: September 2016
Phase: N/A
Study type: Interventional

A randomized controlled clinical trial comparing the effect of substitution of unsaturated fat from nuts and oils for saturated fat from meat and dairy foods on serum lipids in normal weight and obese subjects with elevated LDL cholesterol.

NCT ID: NCT02558452 Not yet recruiting - Quality of Life Clinical Trials

European Transplant Registry of Senior Renal Transplant Recipients on Advagraf

SENIOR
Start date: December 2016
Phase: N/A
Study type: Observational [Patient Registry]

SENIOR transplant Registry European transplant registry of senior renal transplant recipients (above the age of 65 years) receiving initial immunosuppression with tacrolimus once daily, mycophenolate and steroids to investigate long term outcomes on an observational basis.

NCT ID: NCT02548793 Completed - Coronary Disease Clinical Trials

CPR Education Via a Mobile Application Compared to VSI Kit

Start date: January 2016
Phase: N/A
Study type: Interventional

Prompt delivery of cardiopulmonary resuscitation (CPR) is a crucial determinant of survival for many victims of sudden cardiac arrest (SCA), yet bystander CPR is provided in less than one third of witnessed SCA events. A number of barriers to bystander CPR training have been identified including time and cost of the training course. Since the large majority of arrest events occur in the home environment, studies have suggested that providing CPR training to family members of hospitalized cardiac patients may serve as a useful approach to address an environment in which bystander CPR is frequently not provided. Utilizing an existing in-hospital program to train adult family members, the investigators will assess the skills of those who learn CPR through two different educational methods: a mobile app and video self-instruction (VSI).

NCT ID: NCT02490683 Active, not recruiting - Obesity Clinical Trials

Effects of Soy Based Dietary Supplements on Cardiometabolic Risk Factors.

Start date: October 2015
Phase: N/A
Study type: Interventional

This study will test the effect of both Luna Rich X© and Reliv Now© against placebo pills or powder (control) on blood lipids. It will also explore the potential effects of these dietary supplements on inflammation markers and other biological and anthropometric measures. The study intervention will be 30 weeks in length. Twenty four subjects with 2 or more cardiometabolic risk factors will be randomized to participate in the study.

NCT ID: NCT02479568 Completed - Clinical trials for Cardiovascular Risk Factors

Beneficial Impact of Orange Juice Consumption on Risk Factors Associated With Cardiovascular Diseases

CITRUS
Start date: January 12, 2016
Phase: Phase 3
Study type: Interventional

The primary aim is to examine both the acute and chronic effects of hesperidin consumption from 100% Florida orange juice in various doses on functional and systemic markers associated with cardiovascular disease (CVD) risks.

NCT ID: NCT02340598 Completed - Clinical trials for Cardiovascular Risk Factors

Pilot Study of Effects of Cold Vests on Cardiovascular Risk Markers

Start date: January 2015
Phase: N/A
Study type: Interventional

Randomized trial of supplying a cold vest as compared with controls (no cold vest) on cardiovascular risk factors such as blood lipids, insulin, blood pressure and body weight and also on basal metabolic rate. Recruitment of 100 participants and 70 are randomized to being given a vest which they can use to increase basal metabolic rate during 1-2 hours (as long as the pre-cooled vest stays cool) by activating brown adipose tissue and/or shivering. The remaining 30 subjects will constitute a control group. Lab tests and anthropometrics are checked at baseline, after 2 months and after 1 year.

NCT ID: NCT02313831 Recruiting - Clinical trials for Coronary Artery Disease

Optimization of Interval Exercise Based-intensity on Ventilatory Anaerobic Threshold in Coronary Artery Disease

Start date: August 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of interval training, based-intensity on 70% at 110% of oxygen consumption and workload attained on ventilatory anaerobic threshold, on aerobic functional capacity, autonomic modulation of heart rate, metabolic profile in patients with and without coronary artery disease.